Prenetics Global is trading 5.45% up at $23.24, supported by stronger U.S. equities, improving risk appetite and a biotechnology-sector rally.
- Premarket coverage showed the stock at $23.32, up 5.90% from the September 16 close.
- No fresh company-specific catalyst was identified for September 17, 2026; the move is best attributed to global market and sector momentum, rather than a new corporate announcement.